GRPR and breast carcinoma: A second group of radiolabeled GRPR-antagonists were based on the [Dphe6,Sta13,Leu14-NH2]BBN(6-14) motif [105], with a number of analogs tested in a small number of prostate and breast cancer patients in combination with SPECT or PET.